Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,826 - 1,850 of 2,573

«
1
…
72
73
74
75
76
…
103
»

Combination Immunotherapy for Lung Cancer

Combination Immunotherapy for Lung Cancer

By: Scott Antonia, MD, PhD

Immunotherapy in Neoadjuvant - Adjuvant &Stage III NSCLC

Immunotherapy in Neoadjuvant - Adjuvant &Stage III NSCLC

By: Solivan, Pedro

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

By: Stephen Liu, MD

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

By: Stephen Liu, MD

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

By: Stephen Liu, MD

TROP-2 and AXL as Targets in NSCLC

TROP-2 and AXL as Targets in NSCLC

By: Stephen Liu, MD

TROP-2 and AXL as Targets in NSCLC

TROP-2 and AXL as Targets in NSCLC

By: Stephen Liu, MD

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

By: Stephen V. Liu, MD

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1

By: Stephen V. Liu, MD

Approach to lung cancer in the UK

Approach to lung cancer in the UK

By: Steve Bandula, MD, PhD

Locally Advanced NSCLC- Radiation Therapy

Locally Advanced NSCLC- Radiation Therapy

By: Sue Yom, MD, PhD

Locally Advanced NSCLC-Radiation Therapy

Locally Advanced NSCLC-Radiation Therapy

By: Sue Yom, MD, PhD

Locally Advanced NSCLC- Radiation Therapy

Locally Advanced NSCLC- Radiation Therapy

By: Sue Yom, MD, PhD

Session II - Locally Advanced Non-Small Cell Lung CancerPathology and Biology

Session II - Locally Advanced Non-Small Cell Lung CancerPathology and Biology

By: Sue Yom, MD, PhD, Primo Lara, Jr, MD, Leah Backhus, MD, Tianhong “Tina” Li, MD, PhD

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Immunotherapy for Advanced Non-Small Cell Lung Cancer

By: Sukhmani K Padda

Small Cell Lung Cancer Novel Approaches

Small Cell Lung Cancer Novel Approaches

By: Sukhmani K. Padda, MD

Immunotherapy for Advanced Non-Small Cell Lung Cancer

Immunotherapy for Advanced Non-Small Cell Lung Cancer

By: Sukhmani K. Padda, MD

Updates in Immunotherapy for Lung Cancer

Updates in Immunotherapy for Lung Cancer

By: Sukhmani Padda (Stanford)

By: Sukhmani Padda (Stanford), Jonathan W. Riess (UCD), Ravi Salgia (COH), H. Jack West (COH)

Small Cell Lung Cancer: Novel Approaches

Small Cell Lung Cancer: Novel Approaches

By: Sukhmani Padda, MD

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

By: Surbhi Singhal, MD

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

By: Surbhi Singhal, MD

2024 Locally Advanced NSCLC
Neoadjuvant/Adjuvant/Multi-Modality

2024 Locally Advanced NSCLC Neoadjuvant/Adjuvant/Multi-Modality

By: Sylvia Lee, MD

Lung Immunotherapy

Lung Immunotherapy

By: Tejas Patil, MD

Lung Immunotherapy

Lung Immunotherapy

By: Tejas Patil, MD

«
1
…
72
73
74
75
76
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok